BB

Bharatkumar Bhupendrabhai Patel

Active Director Director DIN 10961739
DIN 10961739 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bharatkumar Bhupendrabhai Patel

Data last updated:

Bharatkumar Bhupendrabhai Patel is a Director at Zetabiotics Private Limited (since 2025). The company operates in Pharma.

DIN 10961739
Primary Designation Director
Industry Pharma
First Appointment 21 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zetabiotics Private Limited U46497GJ2025PTC159211
Director21 Feb 20252025Active

Board colleagues of Bharatkumar Bhupendrabhai Patel

NameDINCompanyDesignation
Rakeshkumar Indubhai Patel08434375Zetabiotics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zetabiotics Private Limited
Premium access

Shareholding and investment profile for Bharatkumar Bhupendrabhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bharatkumar Bhupendrabhai Patel

Bharatkumar Bhupendrabhai Patel currently holds 1 directorship: Zetabiotics Private Limited (Director, since 21 Feb 2025).

Bharatkumar Bhupendrabhai Patel was first appointed on 21 Feb 2025 as Director at Zetabiotics Private Limited.

The current boards of Bharatkumar Bhupendrabhai Patel's companies include Rakeshkumar Indubhai Patel (Zetabiotics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available